Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
2002 2
2004 1
2005 4
2006 4
2007 7
2008 5
2009 6
2010 4
2011 7
2012 5
2013 8
2014 3
2015 6
2016 4
2017 2
2018 2
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 23829813

63 results
Results by year
Filters applied: . Clear all
Page 1
Effect of active hexose-correlated compound in women receiving adjuvant chemotherapy for breast cancer: a retrospective study.
Hangai S, Iwase S, Kawaguchi T, Kogure Y, Miyaji T, Matsunaga T, Nagumo Y, Yamaguchi T. Hangai S, et al. J Altern Complement Med. 2013 Nov;19(11):905-10. doi: 10.1089/acm.2012.0914. Epub 2013 Jul 5. J Altern Complement Med. 2013. PMID: 23829813 Free PMC article.
Comparison of pigmentary side effects of taxanes and anthracyclines: an onychoscopic evaluation.
Yorulmaz A, Dogan M, Artuz F, Zengin N. Yorulmaz A, et al. Cutan Ocul Toxicol. 2017 Jun;36(2):135-139. doi: 10.3109/15569527.2016.1173698. Epub 2016 May 10. Cutan Ocul Toxicol. 2017. PMID: 27086693
TAXTOX - a retrospective study regarding the side effects of docetaxel given as part of the adjuvant treatment to patients with primary breast cancer in Denmark from 2007 to 2009.
Eckhoff L, Nielsen M, Moeller S, Knoop A. Eckhoff L, et al. Acta Oncol. 2011 Oct;50(7):1075-82. doi: 10.3109/0284186X.2011.602111. Epub 2011 Aug 9. Acta Oncol. 2011. PMID: 21824038
Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.
Yanagimoto H, Satoi S, Yamamoto T, Hirooka S, Yamaki S, Kotsuka M, Ryota H, Michiura T, Inoue K, Matsui Y, Tsuta K, Kon M. Yanagimoto H, et al. Nutr Cancer. 2016;68(2):234-40. doi: 10.1080/01635581.2016.1134597. Epub 2016 Feb 4. Nutr Cancer. 2016. PMID: 26847832 Clinical Trial.
Sequential versus concurrent anthracyclines and taxanes as adjuvant chemotherapy of early breast cancer: a meta-analysis of phase III randomized control trials.
Shao N, Wang S, Yao C, Xu X, Zhang Y, Zhang Y, Lin Y. Shao N, et al. Breast. 2012 Jun;21(3):389-93. doi: 10.1016/j.breast.2012.03.011. Epub 2012 Apr 26. Breast. 2012. PMID: 22542064 Free article. Clinical Trial.
Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment: the effect of the addition of taxanes.
Davis AL, Klitus M, Mintzer DM. Davis AL, et al. Clin Breast Cancer. 2005 Dec;6(5):421-4. doi: 10.3816/CBC.2005.n.046. Clin Breast Cancer. 2005. PMID: 16381625
Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
Le Deley MC, Suzan F, Cutuli B, Delaloge S, Shamsaldin A, Linassier C, Clisant S, de Vathaire F, Fenaux P, Hill C. Le Deley MC, et al. J Clin Oncol. 2007 Jan 20;25(3):292-300. doi: 10.1200/JCO.2006.05.9048. Epub 2006 Dec 11. J Clin Oncol. 2007. PMID: 17159192
The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
Hirose A, Sato E, Fujii H, Sun B, Nishioka H, Aruoma OI. Hirose A, et al. Toxicol Appl Pharmacol. 2007 Jul 15;222(2):152-8. doi: 10.1016/j.taap.2007.03.031. Epub 2007 Apr 20. Toxicol Appl Pharmacol. 2007. PMID: 17555784
Reduction of adverse effects by a mushroom product, active hexose correlated compound (AHCC) in patients with advanced cancer during chemotherapy--the significance of the levels of HHV-6 DNA in saliva as a surrogate biomarker during chemotherapy.
Ito T, Urushima H, Sakaue M, Yukawa S, Honda H, Hirai K, Igura T, Hayashi N, Maeda K, Kitagawa T, Kondo K. Ito T, et al. Nutr Cancer. 2014;66(3):377-82. doi: 10.1080/01635581.2014.884232. Epub 2014 Mar 10. Nutr Cancer. 2014. PMID: 24611562 Clinical Trial.
Population-based assessment of emergency room visits and hospitalizations among women receiving adjuvant chemotherapy for early breast cancer.
Enright K, Grunfeld E, Yun L, Moineddin R, Ghannam M, Dent S, Eisen A, Trudeau M, Kaizer L, Earle C, Krzyzanowska MK. Enright K, et al. J Oncol Pract. 2015 Mar;11(2):126-32. doi: 10.1200/JOP.2014.001073. Epub 2015 Jan 20. J Oncol Pract. 2015. PMID: 25604597
63 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page